Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Home
Search
PMID 28318215

Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus.

American family physician2017PMID: 28318215

Randomized Controlled TrialSemaglutide

Authors

Ebell, Mark H

Semaglutide Reduces CV Events in High-Risk Patients with Type 2 Diabetes Mellitus. | Pepdox